Publications by authors named "Kazuma Ikeda"

Claim this Profile
S
Selective vanillate production from sugarcane bagasse-derived aromatic compounds using an engineered Pseudomonas sp. NGC7-based strain.
Md Jahangir Alam, Naoya Kodama, Kazuma Ikeda, Kanami Muraki, Yudai Higuchi

J Biosci Bioeng· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of charge balance and hydrophobicity of the surface of cytochrome c on the distribution behaviour in an ionic liquid/buffer biphasic system.
Kazuma Ikeda, Kyoko Fujita, Hiroyuki Ohno, Nobuhumi Nakamura

Org Biomol Chem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis education and certification for nurses.
Kazuma Ikeda, Kenneth E Nollet, Hans Vrielink, Hitoshi Ohto

Transfus Apher Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis.
Hisakazu Nishimori, Nobuharu Fujii, Keiko Fujii, Tohru Ikeda, Naomi Asano, Kazuma Ikeda

Int J Hematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
Daisuke Ennishi, Yoshinobu Maeda, Nobuharu Fujii, Eisei Kondo, Katsuji Shinagawa, Kazuma Ikeda

Leuk Lymphoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
Noriko Namba, Keitaro Matsuo, Shiro Kubonishi, Tomoko Kikuchi, Yoshinobu Maeda, Kazuma Ikeda

Transfusion· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma.
Hisakazu Nishimori, Nobuharu Fujii, Yoshinobu Maeda, Ken-Ichi Matsuoka, Katsuto Takenaka, Kazuma Ikeda

Anticancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
Koichiro Kobayashi, Yoshinobu Maeda, Yoshitaka Hara, Miyuki Nishie-Kataoka, Hisakazu Nishimori, Kazuma Ikeda

Anticancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.
Hisakazu Nishimori, Keitaro Matsuo, Yoshinobu Maeda, Yuichiro Nawa, Kazutaka Sunami, Kazuma Ikeda

Int J Hematol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The biological characteristics of peripheral blood CD123+ myeloid dendritic cell].
Jun Shi, Min Wang, Yun Wan, Kazuma Ikeda

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.
Yasushi Hiramatsu, Yoshinobu Maeda, Nobuharu Fujii, Takashi Saito, Yuichiro Nawa, Kazuma Ikeda

Int J Hematol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CD123+ myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential.
Jun Shi, Kazuma Ikeda, Yosinobu Maeda, Katsuji Shinagawa, Aiji Ohtsuka

Cancer Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does rituximab really induce hepatitis C virus reactivation?
Daisuke Ennishi, Masahiro Yokoyama, Yasuhito Terui, Kengo Takeuchi, Kazuma Ikeda

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased incidence of interstitial pneumonia by CHOP combined with rituximab.
Daisuke Ennishi, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Shunji Takahashi, Kazuma Ikeda

Int J Hematol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
Daisuke Ennishi, Masahiro Yokoyama, Yuko Mishima, Chie Watanabe, Yasuhito Terui, Kazuma Ikeda

Leuk Lymphoma· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid hematopoietic progenitor mobilization by sulfated colominic acid.
Shiro Kubonishi, Tomoko Kikuchi, Shinya Yamaguchi, Hirokazu Tamamura, Nobutaka Fujii, Kazuma Ikeda

Biochem Biophys Res Commun· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.
Kozo Masuda, Akio Hiraki, Nobuharu Fujii, Toshiyuki Watanabe, Motoyuki Tanaka, Kazuma Ikeda

Cancer Sci· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominant infiltration of monocytes in chronic graft-versus-host disease.
Noriko Namba, Katsuji Shinagawa, Nobuharu Fujii, Yoshinobu Maeda, Fumihiko Ishimaru, Kazuma Ikeda

Transplantation· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphoproliferative disorder with regulatory T-cell phenotype.
Tomoko Kikuchi, Yoshio Katayama, Shiro Kubonishi, Toshiyuki Watanabe, Yukari Watanabe, Kazuma Ikeda

Am J Hematol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
Nobuharu Fujii, Kazuma Ikeda, Motoko Koyama, Kazutoshi Aoyama, Taro Masunari

Int J Hematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.
Nobuharu Fujii, Akio Hiraki, Keisuke Aoe, Tomoyuki Murakami, Kazuma Ikeda

Int J Mol Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cytotoxicity of IFN-gamma-activated dendritic cells to freshly isolated acute myeloid leukemia cells].
Jun Shi, Yi Zhang, Ji-Ying Su, Xiao Li, Quan Pu, Kazuma Ikeda

Zhongguo Shi Yan Xue Ye Xue Za Zhi· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells.
Jun Shi, Kazuma Ikeda, Nobuharu Fujii, Eisei Kondo, Katsuji Shinagawa

Cancer Sci· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors for PBPC collection efficiency and collection predictors.
Kazuma Ikeda, Teruhiko Kozuka, Mine Harada

Transfus Apher Sci· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Masami Niiya, Kenji Niiya, Misako Shibakura, Noboru Asaumi, Chikamasa Yoshida, Kazuma Ikeda

Oncology· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis